Viewing Study NCT06961669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-08 @ 10:25 PM
Study NCT ID: NCT06961669
Status: RECRUITING
Last Update Posted: 2025-05-29
First Post: 2025-04-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
Sponsor: Anhui Provincial Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoblastic Leukemia View
None Relapsed or Refractory Multiple Myeloma (RRMM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell lymphoma View
None Relapsed or Refractory Multiple Myeloma View
None Acute B-Cell Leukemia View